Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

renal · Mechanism Report

Can below-optimal eGFR amplify circulating TMAO?

Lower kidney filtration can raise circulating TMAO by reducing its elimination.

PlausibleAugust 21, 20264 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Trimethylamine N-oxide is partly cleared through the kidneys, so a below-optimal estimated glomerular filtration rate can amplify circulating trimethylamine N-oxide even when microbial production is unchanged.

laying out figure…
1 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

TMAO is partly cleared through the kidneys, so its blood level reflects both how much is produced and how well it is eliminated. When eGFR is below optimal, reduced clearance can retain more TMAO and increase circulating concentration. This means an elevated TMAO result should be interpreted in the context of renal function.

Verified conclusion

TMAO is a gut microbe–derived, diet-influenced metabolite whose plasma concentration reflects both production and elimination. In older adults, kidney function is therefore a major interpretive context for an elevated TMAO result.

Renal clearance and circulating concentration

  • Human measured-GFR, timed-urine, LC–MS/MS data show that TMAO clearance closely approximates GFR, with mean fractional excretion 105% ± 32%. This supports efficient filtration as a principal elimination route, with little net tubular reabsorption or secretion in that study.
  • Plasma TMAO was inversely associated with measured GFR (r² = 0.388; P < 0.001). Thus, a lower eGFR can increase circulating TMAO through reduced elimination alone.
  • In controlled CKD metabolic studies, TMAO concentrations were approximately 3-fold higher in stage 3 CKD, 7-fold higher in stages 4–5, and 28-fold higher in dialysis-dependent patients than in controls. Hemodiafiltration markedly removed TMAO, and transplantation normalized concentrations.

Population-level evidence

  • A meta-analysis of 32 studies (42,062 participants) found advanced CKD associated with 67.9 μmol/L higher TMAO and a substantial inverse TMAO–GFR relationship. Concentrations generally rise when eGFR falls below about 60 mL/min/1.73 m².

Mechanistic interpretation

  • Reduced filtration provides a direct retention mechanism: if TMAO input remains constant, lower renal clearance raises its steady-state plasma concentration.
  • The specific condition of unchanged microbial production is mechanistically credible but not directly demonstrated in the cited CKD comparisons; microbial TMA production, diet, and hepatic FMO3 activity were not measured across GFR strata.

Bottom line

  • TMAO is substantially cleared by the kidneys, and reduced eGFR can materially amplify plasma TMAO via retention. An elevated level in a 71-year-old man should therefore not be interpreted as evidence of increased microbial TMAO production without considering renal function.

References

  1. Balancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide — pubs.acs.org ↗
  2. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease — pmc.ncbi.nlm.nih.gov ↗
  3. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease — journals.plos.org ↗
  4. Gut Microbiota-Dependent Trimethylamine N-oxide (TMAO ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes urinary albumin-to-creatinine ratio detect albumin leakage from kidney barrier injury?→Plausible8 sourcesCan impaired kidney filtration raise blood TMAO levels independently of gut microbial production?→